Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Neoplasms 3 Esophageal Neoplasms 2 Stomach Neoplasms 1 Platelet Glycoprotein IV Deficiency 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Cyst 1 Neoplasm Metastasis 1 Leiomyoma 1 Jaundice, Obstructive 1 Gastrointestinal Stromal Tumors 1 Fatty Liver 1 Disease 1 Cysts 1 Colonic Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Adrenal Gland Neoplasms 1 Adrenal Gland Diseases 1 Adenocarcinoma 1

Interventions

Oxaliplatin 200 Capecitabine 116 S 1 (combination) 106 Fluorouracil 105 Docetaxel 100 Cisplatin 88 Leucovorin 75 Paclitaxel 71 Irinotecan 68 apatinib 43 sintilimab 42 Drug Therapy 42 Surgical Procedures, Operative 37 Hyperthermic Intraperitoneal Chemotherapy 34 pembrolizumab 32 Radiotherapy 31 Trastuzumab 30 Gastrectomy 23 Nivolumab 22 Epirubicin 22 Tegafur 21 Bevacizumab 21 XELOX 20 titanium silicide 19 camrelizumab 19 tislelizumab 17 Ramucirumab 17 Carboplatin 16 Neoadjuvant Therapy 15 Endoscopic Mucosal Resection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Stomach Neoplasms × Endosonography × Clear all

NCT05051423 2021-09-30

THERRES

University of Medicine and Pharmacy Craiova

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡